Akums Drugs And Pharma Limited (AKUMS)

Volume: 31,799Avg Vol 1W: 5,86,620Avg Vol 1M: 2,89,70052W Range:₹409.3₹635

₹591.55▼ 0.89%

Key Ratios

Market Cap—

Current Price₹591.55

Previous Close₹596.85

High / Low (52w)₹635 / ₹409.3

Volume31,799

Avg Vol (1W)5,86,620

Avg Vol (1M)2,89,700

Stock P/E21.48

Book Value₹216.42

Dividend Yield—

ROE—

ROA—

Revenue (TTM)—

Revenue Growth—

Profit Margin—

Total Debt—

Shares Outstanding—

Face Value₹2

EPS (TTM)₹5.53

P/B2.49

Debt / Equity—

50 DMA₹543.68

200 DMA₹501.04

Day change-0.89%

Price Chart

₹591.55▲ 26.41% · 1Y

2025-10-20

2026-06-16

20-day avg volume: 3.1L shares

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024	Jun 2024	Mar 2024	Dec 2023	Sept 2023	Jun 2023
Revenue	₹1,158 Cr	₹1,160 Cr	₹1,018 Cr	₹1,024 Cr	₹1,056 Cr	₹1,010 Cr	₹1,033 Cr	₹1,019 Cr	₹944 Cr	₹1,083 Cr	₹1,181 Cr	₹970 Cr
EBITDA	₹147 Cr	₹142 Cr	₹89 Cr	₹119 Cr	₹71 Cr	₹91 Cr	₹100 Cr	₹101 Cr	₹-21 Cr	₹71 Cr	₹128 Cr	₹-147 Cr
Net Profit	₹85 Cr	₹66 Cr	₹41 Cr	₹63 Cr	₹148 Cr	₹65 Cr	₹65 Cr	₹60 Cr	₹-41 Cr	₹194 Cr	₹32 Cr	₹-188 Cr
EPS	5.53	4.33	2.66	4.15	9.64	4.26	4.37	4.21	-2.89	13.21	2.22	-13.16

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue	₹4,170 Cr	₹4,212 Cr	₹3,745 Cr	₹3,695 Cr	₹2,744 Cr	₹2,442 Cr
EBITDA	₹363 Cr	₹31 Cr	₹271 Cr	₹-164 Cr	₹189 Cr	₹135 Cr
Net Profit	₹338 Cr	₹-4 Cr	₹95 Cr	₹-253 Cr	₹123 Cr	₹44 Cr
EPS	22.6	-0.28	6.63	-17.65	8.58	357.03

Balance Sheet

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Assets	₹4,113 Cr	₹3,516 Cr	₹3,267 Cr	₹3,069 Cr	₹2,167 Cr	₹2,078 Cr
Total Liabilities	₹1,050 Cr	₹2,796 Cr	₹2,543 Cr	₹2,444 Cr	₹1,280 Cr	₹1,357 Cr
Equity	₹3,064 Cr	₹720 Cr	₹723 Cr	₹625 Cr	₹887 Cr	₹721 Cr
Total Debt	₹0 Cr	₹78 Cr	₹115 Cr	₹13 Cr	₹1 Cr	₹10 Cr

Cash Flow

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Operating	₹546 Cr	₹561 Cr	₹274 Cr	₹87 Cr	₹176 Cr	₹77 Cr
Investing	₹-548 Cr	₹-330 Cr	₹-305 Cr	₹-235 Cr	₹-109 Cr	₹-190 Cr
Financing	₹73 Cr	₹-108 Cr	₹125 Cr	₹236 Cr	₹-91 Cr	₹233 Cr
Free Cash Flow	₹546 Cr	₹561 Cr	₹274 Cr	₹87 Cr	₹176 Cr	₹77 Cr

Shareholding

Promoter 75.26% Institutions 15.72% Public 3.56%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search